Mylan appoints two members to board
This article was originally published in Scrip
Global pharmaceutical company Mylan has appointed Melina Higgins and Rajiv Malik to its board of directors. Prior to joining Canonsburg, Pennsylvania-based Mylan, Ms Higgins served as a partner and in other senior roles at Goldman Sachs from 1989 until her retirement in January 2010. Mr Malik currently serves as president of Mylan and has held leadership positions at the firm since 2007. With the appointments of Ms Higgins and Mr Malik, Mylan expands its board to 13 members.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.